229 related articles for article (PubMed ID: 26904699)
1. Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens.
Weeks AC; Kimple ME
J Investig Med High Impact Case Rep; 2015; 3(3):2324709615603199. PubMed ID: 26904699
[TBL] [Abstract][Full Text] [Related]
2. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Kennedy LD; Ajiboye VO
J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
[TBL] [Abstract][Full Text] [Related]
3. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
4. [An exceptionally severe hyperuricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS)].
Basile C; Montanaro A
G Ital Nefrol; 2003; 20(5):525-8. PubMed ID: 14634969
[TBL] [Abstract][Full Text] [Related]
5. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
[TBL] [Abstract][Full Text] [Related]
6. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
7. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
Vines AN; Shanholtz CB; Thompson JL
Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
[TBL] [Abstract][Full Text] [Related]
8. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
Alakel N; Middeke JM; Schetelig J; Bornhäuser M
Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
[TBL] [Abstract][Full Text] [Related]
10. Rasburicase in cancer-related hyperuricemia.
Rodriguez M; Campara M; Haaf C
Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
[TBL] [Abstract][Full Text] [Related]
11. Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.
Dinnel J; Moore BL; Skiver BM; Bose P
Core Evid; 2015; 10():23-38. PubMed ID: 25610345
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.
Martens KL; Khalighi PR; Li S; White AA; Silgard E; Frieze D; Estey E; Garcia DA; Hingorani S; Li A
Leuk Res; 2020 Feb; 89():106298. PubMed ID: 31945598
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of hyperuricemia in hematological malignancies.
Cairo MS
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S26-31. PubMed ID: 12521386
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer.
Koura S; Parekh V; Parikh AD; Kaur K; Dunn BK
Cureus; 2023 Feb; 15(2):e34557. PubMed ID: 36879689
[TBL] [Abstract][Full Text] [Related]
15. Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults.
McDonnell AM; Lenz KL; Frei-Lahr DA; Hayslip J; Hall PD
Pharmacotherapy; 2006 Jun; 26(6):806-12. PubMed ID: 16716134
[TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
[TBL] [Abstract][Full Text] [Related]
17. Role of i.v. allopurinol and rasburicase in tumor lysis syndrome.
Holdsworth MT; Nguyen P
Am J Health Syst Pharm; 2003 Nov; 60(21):2213-22; quiz 2223-4. PubMed ID: 14619112
[TBL] [Abstract][Full Text] [Related]
18. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase.
Shukla DK; Gupta D; Aggarwal A; Kumar D
Indian J Med Paediatr Oncol; 2017; 38(3):360-362. PubMed ID: 29200691
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
Gartenberg A; Winkel M; Leonard N
Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
